We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

164 hedge funds and large institutions have $972M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 67 increasing their positions, 48 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

631% more call options, than puts

Call options by funds: $636K | Put options by funds: $87K

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

44% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 18

40% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 48

35% more capital invested

Capital invested by funds: $720M → $972M (+$253M)

4% more funds holding

Funds holding: 157 → 164 (+7)

Holders
164
Holders Change
+7
Holders Change %
+4.46%
% of All Funds
2.39%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
26
Increased
67
Reduced
48
Closed
18
Calls
$636K
Puts
$87K
Net Calls
+$549K
Net Calls Change
+$483K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$38.8M
2
EA
Emerald Advisers
Pennsylvania
+$8.56M
3
FLSM
Frazier Life Sciences Management
California
+$8.31M
4
AC
Armistice Capital
New York
+$7.5M
5
BlackRock
BlackRock
New York
+$6.73M

Top Sellers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
-$27.6M
2
DM
Deerfield Management
New York
-$14.2M
3
EC
EcoR1 Capital
California
-$12.6M
4
NLVP
New Leaf Venture Partners
New York
-$8.07M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
HIM
151
Hillsdale Investment Management
Ontario, Canada
$6.45K – – –
NS
152
NBC Securities
Alabama
$6K – – –
Comerica Bank
153
Comerica Bank
Texas
$4.66K +$357 +28 +11%
Daiwa Securities Group
154
Daiwa Securities Group
Japan
$4K – – –
LFG
155
Larson Financial Group
Missouri
$2.85K – – –
CAL
156
Capital Advisors Ltd
Ohio
$2K – – –
GWS
157
Glassman Wealth Services
Virginia
$1.55K – – –
GRP
158
Global Retirement Partners
California
$1.45K – – –
FFA
159
Farther Finance Advisors
California
$1.11K +$816 +64 +1,280%
PA
160
Parallel Advisors
California
$1K -$2.37K -186 -75%
Carson Wealth (CWM LLC)
161
Carson Wealth (CWM LLC)
Nebraska
$1K -$727 -57 -44%
GI
162
GAMMA Investing
California
$974 +$867 +68 New
FHA
163
First Horizon Advisors
Tennessee
$483 – – –
EC
164
EcoR1 Capital
California
– -$12.6M -993,000 Closed
CWM
165
CIBC World Markets
New York
– -$3.82M -300,000 Closed
Pictet Asset Management
166
Pictet Asset Management
Switzerland
– -$2.78M -218,743 Closed
AA
167
AlphaCentric Advisors
Puerto Rico
– -$1.68M -132,000 Closed
Squarepoint
168
Squarepoint
New York
– -$816K -64,159 Closed
DFCM
169
Dark Forest Capital Management
Puerto Rico
– -$766K -60,216 Closed
MCM
170
Moore Capital Management
New York
– -$636K -50,000 Closed
Tudor Investment Corp
171
Tudor Investment Corp
Connecticut
– -$537K -42,238 Closed
HWAM
172
Hennion & Walsh Asset Management
New Jersey
– -$432K -33,942 Closed
Ohio Public Employees Retirement System (OPERS)
173
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$371K -29,130 Closed
EGM
174
Engineers Gate Manager
New York
– -$342K -26,857 Closed
XT
175
XTX Topco
Cayman Islands
– -$326K -25,628 Closed
4 5 6
7
8

DCPH Hedge Fund Activity: Q4 2023 in Review

164 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q4 2023, worth a combined $972M — up 35% from $720M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new DCPH positions and 18 closed out — a net gain of 8 holders — while 67 added to existing stakes and 48 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $38.8M. The largest seller was Braidwell, cutting an estimated $27.6M.

  • 164 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q4 2023, up from 157 in Q3 2023.
  • Funds reported $972M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q4 2023, up 35% quarter-over-quarter.
  • 26 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q4 2023 and 18 closed out, a net change of +8 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q4 2023 was Morgan Stanley, an estimated $38.8M added.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q4 2023 was Braidwell, an estimated $27.6M sold.

Based on aggregated 13F filings for Q4 2023.